Search hospitals > New York > Commack

MSK Commack

Claim this profile
Commack, New York 11725
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Lung Cancer
Conducts research for Breast Cancer
Conducts research for Colorectal Cancer
Conducts research for Cancer
5 reported clinical trials
0 medical researchers
Photo of MSK Commack in CommackPhoto of MSK Commack in CommackPhoto of MSK Commack in Commack

Summary

MSK Commack is a medical facility located in Commack, New York. This center is recognized for care of Non-Small Cell Lung Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Cancer and other specialties. MSK Commack is involved with conducting 5 clinical trials across 39 conditions. There are 0 research doctors associated with this hospital, such as .

Area of expertise

1Non-Small Cell Lung Cancer
MSK Commack has run 5 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive
2Lung Cancer
MSK Commack has run 4 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
Stage III
PD-L1 positive

Top PIs

Clinical Trials running at MSK Commack

Breast Cancer
Colorectal Cancer
Multiple Myeloma
Brain Tumor
Bladder Cancer
Melanoma
Cancer
Thyroid Cancer
Stomach Cancer
Lymphoma
Image of trial facility.

Disitamab Vedotin + Tucatinib

for Breast Cancer

This clinical trial is studying solid tumor cancers. A solid tumor is one that starts in part of your body like your lungs or liver instead of your blood. Once they've grown bigger in one spot or spread to other parts of the body, they're harder to treat. This is called advanced or metastatic cancer. Participants in this study must have breast cancer or gastric cancer. Participants must have tumors that have HER2 on them. This allows the cancer to grow more quickly or spread faster. There are few treatment options for patients with advanced or metastatic solid tumors that express HER2. This clinical trial uses an experimental drug called disitamab vedotin (DV). Disitamab vedotin is a type of antibody drug conjugate or ADC. ADCs are designed to stick to cancer cells and kill them. This clinical trial uses a drug called tucatinib, which has been approved to treat cancer in the United States and some other countries. This drug is sold under the brand name TUKYSA®. This study will test how safe and how well DV with tucatinib works for participants with solid tumors. This study will also test what side effects happen when participants take these drugs. A side effect is anything a drug does to the body besides treating the disease.
Recruiting1 award Phase 26 criteria

Similar Hospitals nearby

Select from list below to view details

Frequently asked questions

What kind of research happens at MSK Commack?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security